We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+16.07%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$2.92B
AUM Growth
+$330M
Cap. Flow
-$53.3M
Cap. Flow %
-1.82%
Top 10 Hldgs %
49.2%
Holding
64
New
1
Increased
21
Reduced
33
Closed

Top Buys

Rank Stock Value
1
NEOG icon
Neogen
NEOG
+$16.8M
2
CVLT icon
Commault Systems
CVLT
+$8.83M
3
DXCM icon
DexCom
DXCM
+$4.24M
4
CRNC icon
Cerence
CRNC
+$3.98M
5
TECH icon
Bio-Techne
TECH
+$2.59M

Top Sells

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$34M
2
AVAV icon
AeroVironment
AVAV
+$13.6M
3
ILMN icon
Illumina
ILMN
+$12.3M
4
MEDP icon
Medpace
MEDP
+$6.96M
5
FDS icon
Factset
FDS
+$6.76M

Sector Composition

Rank Sector Weight
1 Technology 47.12%
2 Healthcare 30.4%
3 Industrials 10.73%
4 Financials 6.19%
5 Consumer Discretionary 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYBR
1
DELISTED
CyberArk
CYBR
$185M 6.32%
843,670
-6,345
-0.7% -$1.18M
MANH icon
2
Manhattan Associates
MANH
$11.4B
$178M 6.09%
826,940
-160,842
-16% -$34M
AVAV icon
3
AeroVironment
AVAV
$9.45B
$169M 5.78%
1,340,752
-110,786
-8% -$13.6M
IDXX icon
4
Idexx Laboratories
IDXX
$46.2B
$168M 5.74%
302,300
-4,075
-1% -$1.91M
ICLR icon
5
Icon
ICLR
$12.7B
$145M 4.96%
512,728
-11,252
-2% -$2.91M
FTNT icon
6
Fortinet
FTNT
$117B
$139M 4.77%
2,382,059
-31,100
-1% -$1.72M
QLYS icon
7
Qualys
QLYS
$6.35B
$134M 4.59%
684,244
-5,432
-0.8% -$950K
MEDP icon
8
Medpace
MEDP
$16.5B
$121M 4.14%
395,120
-25,800
-6% -$6.96M
ANSS
9
DELISTED
Ansys
ANSS
$101M 3.45%
277,923
+477
+0.2% +$141K
NICE icon
10
Nice
NICE
$5.97B
$98M 3.35%
491,372
-1,841
-0.4% -$331K
FDS icon
11
Factset
FDS
$10.2B
$92.8M 3.17%
194,427
-15,012
-7% -$6.76M
RMD icon
12
ResMed
RMD
$30.7B
$86.3M 2.95%
501,551
+1,289
+0.3% +$198K
GNTX icon
13
Gentex
GNTX
$5.07B
$77.4M 2.65%
2,371,264
-9,573
-0.4% -$296K
JKHY icon
14
Jack Henry & Associates
JKHY
$11.1B
$76.6M 2.62%
468,789
-8,758
-2% -$1.34M
TECH icon
15
Bio-Techne
TECH
$11.3B
$74.1M 2.53%
960,092
+39,393
+4% +$2.59M
CSGP icon
16
CoStar Group
CSGP
$12.3B
$71.7M 2.45%
820,097
-13,225
-2% -$1.07M
RBC icon
17
RBC Bearings
RBC
$18B
$63.9M 2.18%
224,208
+2,912
+1% +$714K
CGNX icon
18
Cognex
CGNX
$11.3B
$63.2M 2.16%
1,514,881
-13,544
-0.9% -$520K
VEEV icon
19
Veeva Systems
VEEV
$37.4B
$62.3M 2.13%
323,391
+12,414
+4% +$2.34M
CVLT icon
20
Commault Systems
CVLT
$5.61B
$56.2M 1.92%
703,975
+123,512
+21% +$8.83M
GWRE icon
21
Guidewire Software
GWRE
$14.2B
$48.8M 1.67%
447,363
-1,702
-0.4% -$162K
DXCM icon
22
DexCom
DXCM
$32B
$45.1M 1.54%
363,388
+41,539
+13% +$4.24M
CRL icon
23
Charles River Laboratories
CRL
$12.8B
$43.3M 1.48%
183,300
+300
+0.2% +$59K
KRNT icon
24
Kornit Digital
KRNT
$791M
$42M 1.44%
2,190,623
-8,920
-0.4% -$155K
BLKB icon
25
Blackbaud
BLKB
$2.08B
$41.8M 1.43%
482,618
-3,010
-0.6% -$228K

Similar funds

American Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, American Capital Management held 64 positions worth $2.92B, up 13% from $2.59B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 1.6%. American Capital Management opened 1 new position and made no exits, leaving the 64-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 47% a quarter earlier, followed by Healthcare and Industrials.

  • American Capital Management's largest Q4 2023 buy was Insulet: 11,765 shares worth $2.55M.
  • American Capital Management added most to Neogen in Q4 2023, an estimated $16.8M increase.
  • American Capital Management's biggest Q4 2023 reduction was Manhattan Associates, cutting an estimated $34M.
  • American Capital Management's ten largest holdings make up 49% of its $2.92B portfolio in Q4 2023.
  • American Capital Management opened 1 new position and closed 0 in Q4 2023.
  • American Capital Management's portfolio value rose 13% quarter-over-quarter to $2.92B.

Based on American Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.